Lantheus Holdings Operating Expenses 2013-2025 | LNTH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Lantheus Holdings operating expenses from 2013 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Lantheus Holdings Operating Expenses 2013-2025 | LNTH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Lantheus Holdings operating expenses from 2013 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$228.4B
Boston Scientific (BSX)	$153.7B
Stryker (SYK)	$149.1B
EssilorLuxottica (ESLOY)	$146B
Medtronic (MDT)	$115.2B
Lonza Group Ag (LZAGY)	$48.5B
Haleon (HLN)	$43.7B
ResMed (RMD)	$41.9B
Agilent Technologies (A)	$34.1B
GE HealthCare Technologies (GEHC)	$33.8B
Terumo (TRUMY)	$27.8B
Koninklijke Philips (PHG)	$26.5B
Insulet (PODD)	$23.1B
Zimmer Biomet Holdings (ZBH)	$20.7B
Smith & Nephew SNATS (SNN)	$16.2B
Baxter (BAX)	$12.5B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.8B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
Perrigo (PRGO)	$3.2B
Prestige Consumer Healthcare (PBH)	$3.2B
ICU Medical (ICUI)	$3.1B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.8B
Curaleaf Holdings (CURLF)	$1.7B
Green Thumb Industries (GTBIF)	$1.6B